Technology

BioWorld by Clarivate Highlights Gaps in Women’s Health Research and Investment in New Special Series

Published

1 year ago

November 21, 2024

New seven-part series explores disparities in care, funding and innovation impacting half the world’s population

LONDON, Nov. 21, 2024 /PRNewswire/ — BioWorld™ published by Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, has launched its new special series, ‘Healing the Health Divide.‘ This seven-part series sheds light on the persistent disparities in women’s health research, funding, and treatment.

Women make up half of the global population, yet their health remains consistently underserved. Research and treatments have traditionally focused on reproduction and breast health, but these areas represent just a fraction of the broader health challenges women face. From autoimmune disorders to cardiovascular disease, many conditions disproportionately affect women or manifest differently than in men. However, decades of research have excluded women from clinical trials, often due to misconceptions about their “complex physiology.” Meanwhile, male-dominated boardrooms have perpetuated this oversight in funding decisions, exacerbating the issue.

The consequences of this systemic neglect are stark. In 2023, just 15% of venture capital funding was directed to biopharma companies focused on women’s health, and only 8% of funded companies included women’s health assets in their pipelines. These disparities leave critical gaps in care for conditions such as Alzheimer’s disease, which affects women at twice the rate of men, and endometriosis, which impacts approximately 190 million women worldwide, yet often goes undiagnosed for years.

Lynn Yoffee, Publisher of BioWorld, stated: “The new BioWorld special series, ‘Healing the Health Divide,’ is a call to action to address the inequities in women’s health research and investment. The data we’ve uncovered highlights the urgent need for a paradigm shift in how we approach this critical issue. This series not only exposes the disparities but also celebrates the progress being made, with the goal of inspiring industry leaders and scientists to close these gaps and create solutions that benefit all of humanity.”

The series explores underrecognized areas such as the role of gender bias in research, the untapped potential of women’s health markets, and groundbreaking efforts to improve early diagnosis and treatment of conditions like endometriosis and cardiovascular disease.

Featured articles in ‘Healing the Health Divide,’ include:

Despite women’s health inroads, lackluster funding impedes progress
Despite increased interest, progress in women’s health remains hindered by lackluster funding and decades of exclusion from clinical trials. The number of deals focused on women’s health since 2019 comprise just 18.5% of all deals analyzed from the 473 companies and they make up just 20% of the total value of all deals that disclosed terms. This article, by Senior Managing Editor Karen Carey explores the inspiring efforts of women leading the charge to improve health outcomes and secure investments for female-focused solutions.Dynamic infographic on Women’s Health
A compelling visual analysis by Production Editor Ann Marie Griffith of women’s health funding, showcases how venture capital and biopharma companies are beginning to address the vast unmet need — but still have far to go.VCs emerge for women’s health and its ‘groundbreaking’ research
While U.S. government initiatives are supportive, private market investments are essential to advance women’s health innovations. This article highlights emerging venture capital efforts and the challenges of securing funding.The science of gender-based medicine: many reasons, many manifestations
From Alzheimer’s to autoimmune diseases, Managing Editor Anette Breindl, examines how biological and hormonal differences impact disease prevalence and progression in women, emphasizing the importance of gender-specific medical research.Gender bias leaves women at risk in cardiology treatment guidelines
Gender bias in cardiac care has left nearly 70% of women underdiagnosed for cardiovascular disease. Staff Writer Tamra Sami investigates how male-focused clinical trials have skewed treatment guidelines, endangering women’s lives.Holistic strategies needed to diagnose and treat endometriosis
Endometriosis affects 10% of women globally, yet delayed diagnosis and limited understanding have left millions suffering unnecessarily. This article, also produced by Sami, delves into the biological complexity of the disease and the need for comprehensive treatment strategies.New diagnostics, trials address deadly disparities in women’s cardiac care
While women with “big hearts” play well in popular culture, cardiologists see a very different picture – with significant implications for women’s health and medical care, according to an article by Editor Annette Boyle. Women have smaller hearts and smaller blood vessels than men and their cardiovascular systems respond to disease and treatment in very different ways. In 2024, for the first time, major trials of cardiovascular medical devices sought to understand how common interventions work in women and how previous failures to include women in studies translated into higher cardiovascular mortality rates.

BioWorld’s “Healing the Health Divide” underscores the urgent need for equitable investment in women’s health and celebrates the pioneers driving meaningful change.

To access the full special series, visit https://www.bioworld.com/womens_health.

Join the conversation and mention BioWorld on X and LinkedIn as well as Clarivate for Life Sciences & Healthcare on X and LinkedIn.

About BioWorld

With writers and editors stationed around the globe, BioWorld published by Clarivate, reports the breaking news – and provides key perspective on hundreds of therapeutics and devices in development, the companies behind those candidates, the business development transactions that evolve the markets, and the regulatory hurdles that both challenge and guard the processes. BioWorld has a long tradition of excellence in journalism. Collectively, the news services have been honored with 61 awards dating back to 1998.

About Clarivate
Clarivate™ is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. For more information, please visit www.clarivate.com

Media Contact
Catherine Daniel
Director, External Communications, Life Sciences & Healthcare, Clarivate
newsroom@clarivate.com

SOURCE Clarivate Plc

Technology

Luxor Expands LuxOS to MicroBT WhatsMiner, and MicroBT Intends for a Strategic Investment

Published

38 minutes ago

April 27, 2026

SEATTLE, April 26, 2026 /PRNewswire/ — Today, Luxor Technology Corporation (“Luxor”) announces the expansion of LuxOS firmware support to MicroBT WhatsMiner series miners, growing the LuxOS ecosystem. In addition, MicroBT, via its investment manager Inflection Technology Limited (“ITL”), has signed a term sheet to make a strategic investment into Luxor. Luxor has also committed to a US$100,000,000 purchase of MicroBT WhatsMiner hardware.

Luxor is working directly with a select group of mining partners to deploy and expand model support over time. With more than 300,000 Bitcoin mining machines already running LuxOS globally, Luxor brings to the WhatsMiner ecosystem the same enterprise-grade firmware infrastructure that large-scale mining operators rely on. MicroBT hardware represents a significant share of global Bitcoin mining capacity, and with this expansion, those operators now have access to flexible firmware features.

WhatsMiner fleets running LuxOS gain access to Power Targeting, Advanced Thermal Management, safe rapid curtailment, and faster ramp-up time — unlocking new capabilities beyond stock settings. Power Targeting delivers consistent, predictable performance across individual machines and makes infrastructure planning easier at scale. When shifting power targets, LuxOS completes the transition in 30-60 seconds while continuing to hash at higher hashrates — capturing additional hashrate. LuxOS also improves ramp-up time across curtailment events, reaching full capacity faster and reducing the unharvested hashrate lost every time machines cycle. Initial support spans select models in the M50 series. For the full list of supported models, visit docs.luxor.tech.

“We are excited to build on the MicroBT WhatsMiner platform. We are consistently impressed by their ability to execute with high-quality machines. Our clients have been asking for WhatsMiner firmware for years, and we have shipped a product that is going to help deliver significant profitability and usability benefits. We are also excited to welcome MicroBT as a strategic investor.”

— Lauren Lin, Head of Hardware and Software of Luxor

“Luxor has continued to be one of MicroBT’s trusted global partners. With their talented engineering team, we are excited they are building on top of the Whatsminer platform. We are happy to be taking a strategic position in Luxor and supporting their continued growth through this hardware partnership.”

— Dr.Yang, CEO and Co-Founder of MicroBT

Operators running LuxOS have access to Luxor’s full-stack mining experience: pool, hashrate derivatives, energy services, and Luxor Commander for fleet management — unified under a single platform. Commander includes Intelligent Miner, which keeps fleets running at peak profitability by continuously adjusting power settings based on real-time hashprice and energy prices.

Luxor is rolling out LuxOS for WhatsMiner in a phased approach, onboarding operations directly to ensure a high-quality deployment experience. Mining operations running WhatsMiner hardware can express interest in access at luxor.tech/contact.

About Luxor Technology Corporation

Luxor delivers hardware, software, and financial services that power the global compute and energy industry. Its product suite spans Bitcoin Mining Pools, ASIC Firmware, Hardware trading, Hashrate Derivatives, Energy services, a Miner Management software, Commander, and a bitcoin mining data platform, Hashrate Index.

If you are interested in contacting Luxor, please email sales@luxor.tech.

View original content:https://www.prnewswire.com/news-releases/luxor-expands-luxos-to-microbt-whatsminer-and-microbt-intends-for-a-strategic-investment-302753797.html

SOURCE Luxor Technology

Technology

GLN Connects to Vietnam’s National QR Network, Enabling Nationwide QR Payments

Published

2 hours ago

April 26, 2026

Direct access to Vietnam’s nationwide QR payment networkEnabling payments via partners’ home-market banking and fintech apps without currency exchange

SEOUL, South Korea, April 26, 2026 /PRNewswire/ — GLN International has launched a nationwide QR payment service in Vietnam in partnership with NAPAS, marking its direct integration into the country’s national QR payment infrastructure.

The service was introduced at a launch ceremony on April 23 in Vietnam, attended by the State Bank of Vietnam (SBV), NAPAS, BIDV, and Hana Bank.

GLN leads the operation of the payment system connected to Vietnam’s national QR network and has driven its technical integration, as part of Hana Financial Group’s cross-border initiatives. Hana Bank participates as the only Korean financial institution designated as a settlement bank under SBV approval.

Vietnam’s payment infrastructure is built on the VietQR Global system operated by NAPAS, linking banks and merchants nationwide. Through this integration, GLN enables users of partner apps to access the network, expanding acceptance. The partnership is also expected to support inbound use cases, allowing Vietnamese users to make QR payments in Korea via their local apps.

The service is available across tourist destinations, including Da Nang, Phu Quoc, Nha Trang, and Ho Chi Minh City, across everyday merchants. Payments can be made through GLN-connected partner applications, including major Korean fintech apps such as Toss, PurpleGLN, Hana OneQ, Hana Money, and Hana Card, without currency exchange. The service is expected to expand to platforms, including Naver Pay and KB Banking App.

Seok Lee, CEO of GLN, said, “This launch marks a significant step in connecting Korea and Vietnam through a unified QR payment infrastructure. By integrating with Vietnam’s national QR network, we enable a simple payment experience for travelers using the apps they already use in their home market, without currency exchange. We will continue to lead overseas payments and cash withdrawals without physical cards.”

Meanwhile, GLN, a subsidiary of Hana Bank under Hana Financial Group, provides QR payment and QR withdrawal services across 14 countries in Asia, including Vietnam, China, Thailand, the Philippines, Laos, and Japan, with access to more than 200 million QR merchants globally. The company is a leading cross-border payment infrastructure provider in Asia, connecting users and merchants across markets. It has also established partnerships with overseas financial platforms, including Moreta Pay (North America), DeCard App (Singapore), and Taishin Bank (Taiwan).

View original content to download multimedia:https://www.prnewswire.com/news-releases/gln-connects-to-vietnams-national-qr-network-enabling-nationwide-qr-payments-302753730.html

SOURCE GLN International

Technology

VARON Celebrates 5 Years Supporting Easier Breathing for Customers Worldwide

Published

2 hours ago

April 26, 2026

NEW YORK, April 24, 2026 /PRNewswire/ — VARON is celebrating a meaningful milestone, its 5th anniversary, and is taking this moment to thank customers around the world who have trusted its oxygen therapy solutions over the years. What started as a mission to make breathing support more accessible has grown into a global community of users relying on VARON’s advanced oxygen machines in their daily lives.

This anniversary is not just about the company’s growth, but about the people behind it—the individuals and families who have chosen VARON for comfort, independence, and peace of mind.

Five Years of Supporting Easier Breathing and Everyday Living

Over the past five years, VARON has focused on one simple idea: making oxygen therapy easier to use, easier to move with, and easier to trust. From home use to travel needs, the brand has continued improving its range of oxygen machines to support different lifestyles and health needs.

Today, VARON offers a full lineup that includes compact portable oxygen concentrator models and reliable at home oxygen concentrator systems designed for long-term use. Many users also prefer VARON’s lightweight oxygen concentrator options, which allow more freedom of movement without sacrificing performance.

“Our customers are at the center of everything we do,” VARON CEO shared in a message marking the anniversary. “We are deeply grateful for the trust placed in us over the past five years. Every device we create is built with real people and real daily needs in mind.”

Designed for Real Life: Home and On-the-Go Oxygen Support

VARON’s oxygen solutions are designed to fit into everyday routines—whether at home, during travel, or while staying active.

At home users continue to rely on models like the Serene 5 Home Oxygen Concentrator, which delivers steady medical-grade oxygen with quiet operation and simple controls. The Serene 3 offers a compact option for those who want efficient oxygen support in a smaller footprint.

For users needing flexibility, the VH-2 Pro Home Oxygen Concentrator provides adjustable flow settings and added features like nebulization support, making it a practical choice for daily home use.

On the portable side, VARON continues to expand independence for users who need oxygen on the move. The VP-8G Ultra Portable Oxygen Concentrator stands out for its ultra-lightweight design at just 4.37 lbs, making it easy to carry while traveling or running errands. The VP-6 Continuous Portable Oxygen Concentrator and VP-2 Portable Oxygen Concentrator offer additional options with adjustable flow settings and dependable oxygen delivery.

Each portable oxygen concentrator is designed with user comfort in mind—lightweight, easy to operate, and built for mobility without stress.

A Simple Way to Say Thank You: Anniversary Discounts and Free Gifts

To celebrate its 5th year, VARON is launching a limited-time global appreciation event with special savings across its entire product range.

Customers can enjoy featured anniversary offers:

18% OFF sitewide across all oxygen machinesFree VARON gifts, including a $30 store gift card and extra nasal cannulas with every machine purchaseUp to 40% OFF selected featured productsAutomatic discounts applied at checkout—no codes needed

Customers can also save more with bundle options such as the VP-8G Super Bundle and extra battery packages for VP-6 and VP-2 models.

“These anniversary offers are our way of saying thank you,” VARON CEO shared. “We want to make it easier for more people to access reliable oxygen support at home and on the go.”

Looking Ahead with Customers at the Center

As VARON moves into its sixth year, the company remains focused on improving its oxygen therapy technology and expanding accessibility worldwide. Future development will continue to focus on making portable oxygen concentrator devices lighter, more efficient, and easier to use in everyday life.

The goal remains simple: to help more people breathe easier and live with greater confidence and independence.

About VARON

VARON is a trusted provider of oxygen therapy solutions, offering a wide range of at home oxygen concentrator systems, portable oxygen concentrator devices, and advanced oxygen machines designed for home, travel, and personal use. The company is committed to creating lightweight oxygen concentrator technology that supports comfort, mobility, and better quality of life.

For more information on VARON’s 5th anniversary offers and full product lineup, customers are encouraged to visit the official VARON website.

Media Contact:
VARON Oxygen Concentrator
Email: support@varoninc.com
Website: https://varoninc.com/

View original content:https://www.prnewswire.com/news-releases/varon-celebrates-5-years-supporting-easier-breathing-for-customers-worldwide-302753790.html

SOURCE Varon oxygen concentrator